StockMacro
Menu

Lifecore Biomedical

$6.39 +33% in 6 monthsMarket cap $242.2M

LFCR on XNAS, Health Care, Lifecore Biomedical, Inc., job postings

Measures activity, not value. Not investment advice.

Quarterly revenue fell 19% to $25.3M, and debt of $161M far exceeds $23M cash.

  • WatchCapital spending cut 47% to $912K in the latest quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Industry
Pharmaceutical preparations (Health Care)
Employees
382
Website
lifecore.com
Listed
Nasdaq, US
Last results
4 Nov 2026
Next results
expected around 15 Mar 2027 (an estimate: a year ago it reported on 16 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $25.3M, net loss $40.1M.
Quarter to 28 Nov 2021: revenue $129.5M, net income -$38.4MQuarter to 28 Nov 2021: revenue $129.5M, net income -$38.4MQuarter to 27 Feb 2022: revenue $53.1M, net income -$12.8MQuarter to 27 Feb 2022: revenue $53.1M, net income -$12.8MQuarter to 29 May 2022: revenue $47.6M, net income -$36.7MQuarter to 29 May 2022: revenue $47.6M, net income -$36.7MQuarter to 28 Aug 2022: revenue $43.4M, net income -$12.1MQuarter to 28 Aug 2022: revenue $43.4M, net income -$12.1MQuarter to 27 Nov 2022: revenue $38.8M, net income -$12.4MQuarter to 27 Nov 2022: revenue $38.8M, net income -$12.4MQuarter to 26 Feb 2023: revenue $27.6M, net income -$40.2MQuarter to 26 Feb 2023: revenue $27.6M, net income -$40.2MQuarter to 28 May 2023: revenue $31.1M, net income -$39.3MQuarter to 28 May 2023: revenue $31.1M, net income -$39.3MQuarter to 27 Aug 2023: revenue $24.5M, net income -$10.8MQuarter to 27 Aug 2023: revenue $24.5M, net income -$10.8MQuarter to 26 Nov 2023: revenue $30.1M, net income $14.2MQuarter to 26 Nov 2023: revenue $30.1M, net income $14.2MQuarter to 25 Feb 2024: revenue $35.7M, net income $15.6MQuarter to 25 Feb 2024: revenue $35.7M, net income $15.6MQuarter to 25 Aug 2024: revenue $24.7M, net income -$16.2MQuarter to 25 Aug 2024: revenue $24.7M, net income -$16.2MQuarter to 24 Nov 2024: revenue $32.6M, net income -$6.6MQuarter to 24 Nov 2024: revenue $32.6M, net income -$6.6MQuarter to 23 Feb 2025: revenue $35.2M, net income -$14.8MQuarter to 23 Feb 2025: revenue $35.2M, net income -$14.8MQuarter to 25 May 2025: revenue $36.4M, net income -$1.1MQuarter to 25 May 2025: revenue $36.4M, net income -$1.1MQuarter to 30 Sep 2025: revenue $31.1M, net income -$10.0MQuarter to 30 Sep 2025: revenue $31.1M, net income -$10.0MQuarter to 31 Mar 2026: revenue $23.2M, net income -$15.0MQuarter to 31 Mar 2026: revenue $23.2M, net income -$15.0MQuarter to 30 Jun 2026: revenue $34.2M, net income -$6.2MQuarter to 30 Jun 2026: revenue $34.2M, net income -$6.2MQuarter to 30 Sep 2026: revenue $25.3M, net income -$40.1MQuarter to 30 Sep 2026: revenue $25.3M, net income -$40.1M
28 Nov 2021RevenueNet incomeNet losstallest bar $129.5M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$25.3M-$40.1M
30 Jun 2026$34.2M-$6.2M
31 Mar 2026$23.2M-$15.0M
30 Sep 2025$31.1M-$10.0M
25 May 2025$36.4M-$1.1M
23 Feb 2025$35.2M-$14.8M
24 Nov 2024$32.6M-$6.6M
25 Aug 2024$24.7M-$16.2M
25 Feb 2024$35.7M$15.6M
26 Nov 2023$30.1M$14.2M
27 Aug 2023$24.5M-$10.8M
28 May 2023$31.1M-$39.3M
26 Feb 2023$27.6M-$40.2M
27 Nov 2022$38.8M-$12.4M
28 Aug 2022$43.4M-$12.1M
29 May 2022$47.6M-$36.7M
27 Feb 2022$53.1M-$12.8M
28 Nov 2021$129.5M-$38.4M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. – –
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. – -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $23.0M $18.9M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $161.0M $136.0M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $137.9M $117.1M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. – 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. – 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Lifecore BiomedicalLFCR (this company) $242.2M––––
CAMP4 TherapeuticsCAMP $237.8Mloss44.7+40%–
Turn TherapeuticsTTRX $247.5Mloss–––
Standard BioToolsLAB $249.1M–3.0-22%158%
Q32 BioQTTB $249.6M7.7–––
Prelude TherapeuticsPRLD $258.5Mloss12.0+105%-247%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+5.1%

103 13F filers vs 98

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

67%

25.4M shares held by 13F filers (30 Sep 2026) of 37.9M outstanding (28 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.5%

1.7M shares sold short (30 Oct 2026) of 37.9M outstanding (28 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

3.5

1.7M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-4.5%

1.8M shares sold short in the report before, 1.7M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

38%

38% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 45%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

18

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-19%

$25.3M vs $31.1M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-47%

$912K vs $1.7M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

5

5 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.0×

5 articles in the last 7 days; its usual week has 1.

Price $6.39 on 20 Nov 2026, -13% over 12 months (12-month range $3.66 to $8.82)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: -$9.8M).
Revenue per quarter. Revenue $25.3M in the latest quarter, -19% on a year earlier.
Capital spending per quarter. Capital spending $912K in the latest quarter, -47% on a year earlier.
Institutional holders (13F filers). 103 13F filers reported holding it in the latest 13F quarter, +7.3% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
5 Jun 20268-K and other filingsDirector or officer change
5 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Jan 20268-K and other filingsDirector or officer change
16 Jan 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 Sep 20258-K and other filingsDirector or officer change
18 Aug 20258-K and other filingsChanged its auditor
18 Jul 20258-K and other filingsDirector or officer change
18 Jul 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Apr 20258-K and other filingsDirector or officer change
16 Apr 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
10 Oct 20248-K and other filingsRegistered new securities for sale (S-1)
1 Oct 2024Sharp changeShort interest spike: short interest spike, 2.8M vs usual 1.9M (2024-09-13); 1.4x the same period a year earlier
23 Sep 20248-K and other filingsDirector or officer change
17 Sep 2024Sharp changeShort interest spike: short interest spike, 2.9M vs usual 1.8M (2024-08-30); 1.6x the same period a year earlier
29 Aug 20248-K and other filingsDirector or officer change
27 Aug 2024Sharp changeShort interest spike: short interest spike, 2.8M vs usual 1.8M (2024-08-15); 1.7x the same period a year earlier
21 Aug 20248-K and other filingsDirector or officer change
13 Aug 2024Sharp changeShort interest spike: short interest spike, 2.8M vs usual 1.8M (2024-07-31); 1.7x the same period a year earlier
12 Aug 20248-K and other filingsReport will be filed late
30 Jul 2024Sharp changeShort interest spike: short interest spike, 2.8M vs usual 1.8M (2024-07-15); 1.7x the same period a year earlier
24 Jul 20248-K and other filingsDirector or officer change
12 Jul 20248-K and other filingsRestructuring costs announced
1 Jul 20248-K and other filingsDirector or officer change
7 Jun 20248-K and other filingsDelisting notice or listing transfer
22 May 20248-K and other filingsDirector or officer change
14 May 20248-K and other filingsDelisting notice or listing transfer
7 May 20248-K and other filingsDirector or officer change
30 Apr 20248-K and other filingsChanged its auditor
19 Apr 20248-K and other filingsDelisting notice or listing transfer
8 Apr 20248-K and other filingsReport will be filed late
26 Mar 20248-K and other filingsChanged its auditor
20 Mar 20248-K and other filingsDirector or officer change
20 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Feb 20248-K and other filingsDelisting notice or listing transfer
12 Jan 20248-K and other filingsDelisting notice or listing transfer
10 Jan 20248-K and other filingsReport will be filed late
31 Oct 20238-K and other filingsEarlier financial statements can no longer be relied on
18 Oct 20238-K and other filingsDelisting notice or listing transfer
10 Oct 20238-K and other filingsReport will be filed late
22 Aug 20238-K and other filingsDelisting notice or listing transfer
14 Aug 20238-K and other filingsReport will be filed late
6 Jun 20238-K and other filingsRegistered new securities for sale (S-1)
23 May 20238-K and other filingsA major agreement ended
2 May 20238-K and other filingsDirector or officer change
14 Apr 20238-K and other filingsDelisting notice or listing transfer
10 Apr 20238-K and other filingsReport will be filed late
6 Apr 20238-K and other filingsRegistered new securities for sale (S-1)
21 Mar 2023Sharp changeQuarterly revenue change: quarterly revenue change, 38.8M vs usual 129.1M (2022-11-27); 0.3x the same period a year earlier
3 Mar 20238-K and other filingsDirector or officer change
7 Feb 20238-K and other filingsCompleted an acquisition or asset sale
31 Jan 20238-K and other filingsEarlier financial statements can no longer be relied on
11 Jan 20238-K and other filingsDelisting notice or listing transfer
10 Jan 20238-K and other filingsDirector or officer change
9 Jan 20238-K and other filingsReport will be filed late
7 Nov 20228-K and other filingsDirector or officer change
11 Oct 2022Sharp changeQuarterly revenue change: quarterly revenue change, 43.4M vs usual 130.2M (2022-08-28); 0.3x the same period a year earlier
20 Sep 2022Sharp changeQuarterly revenue change: quarterly revenue change, 47.6M vs usual 133.3M (2022-05-29); 0.3x the same period a year earlier
14 Sep 20228-K and other filingsEarlier financial statements can no longer be relied on
9 Sep 20228-K and other filingsDelisting notice or listing transfer
15 Aug 20228-K and other filingsReport will be filed late
10 Aug 20228-K and other filingsDirector or officer change
10 Aug 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Apr 2022Sharp changeQuarterly revenue change: quarterly revenue change, 53.1M vs usual 136.7M (2022-02-27); 0.4x the same period a year earlier
24 Jan 20228-K and other filingsDirector or officer change
20 Dec 20218-K and other filingsDirector or officer change
17 Dec 20218-K and other filingsCompleted an acquisition or asset sale
Insider net buying (open market)
Month from 1 Jan 2022: $4.1M published
Month from 1 Oct 2022: $2.0M published
Month from 1 Jan 2023: $5.0M published
Month from 1 Oct 2024: $7.2M published
Month from 1 Jan 2025: $98K published
Month from 1 May 2025: -$9.9M published
Revenue per quarter
Quarter ended 28 Nov 2021: $129.5M, -1.1% on a year earlier; public on 8 Jan 2022
Quarter ended 27 Feb 2022: $53.1M, -61% on a year earlier; public on 8 Apr 2022
Quarter ended 29 May 2022: $47.6M, -66% on a year earlier; public on 15 Sep 2022
Quarter ended 28 Aug 2022: $43.4M, -66% on a year earlier; public on 8 Oct 2022
Quarter ended 27 Nov 2022: $38.8M, -70% on a year earlier; public on 17 Mar 2023
Quarter ended 26 Feb 2023: $27.6M, -48% on a year earlier; public on 3 Jun 2023
Quarter ended 28 May 2023: $31.1M, -35% on a year earlier; public on 21 Mar 2024
Quarter ended 27 Aug 2023: $24.5M, -43% on a year earlier; public on 10 Aug 2024
Quarter ended 26 Nov 2023: $30.1M, -22% on a year earlier; public on 10 Aug 2024
Quarter ended 25 Feb 2024: $35.7M, +29% on a year earlier; public on 10 Aug 2024
Quarter ended 25 Aug 2024: $24.7M, +0.7% on a year earlier; public on 5 Oct 2024
Quarter ended 24 Nov 2024: $32.6M, +8.0% on a year earlier; public on 3 Jan 2025
Quarter ended 23 Feb 2025: $35.2M, -1.5% on a year earlier; public on 4 Apr 2025
Quarter ended 25 May 2025: $36.4M; public on 6 Aug 2026
Quarter ended 30 Sep 2025: $31.1M; public on 7 Nov 2025
Quarter ended 31 Mar 2026: $23.2M; public on 7 May 2026
Quarter ended 30 Jun 2026: $34.2M; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $25.3M, -19% on a year earlier; public on 5 Nov 2026
Capital spending per quarter
Quarter ended 28 Nov 2021: $5.1M, +83% on a year earlier; public on 8 Jan 2022
Quarter ended 27 Feb 2022: $5.5M, +39% on a year earlier; public on 8 Apr 2022
Quarter ended 28 Aug 2022: $2.9M, -63% on a year earlier; public on 8 Oct 2022
Quarter ended 27 Nov 2022: $3.3M, -36% on a year earlier; public on 17 Mar 2023
Quarter ended 26 Feb 2023: $6.1M, +11% on a year earlier; public on 3 Jun 2023
Quarter ended 27 Aug 2023: $5.1M, +73% on a year earlier; public on 10 Aug 2024
Quarter ended 26 May 2024: $3.1M; public on 8 Aug 2025
Quarter ended 25 Aug 2024: $3.4M, -33% on a year earlier; public on 5 Oct 2024
Quarter ended 23 Feb 2025: $5.5M; public on 7 May 2026
Quarter ended 25 May 2025: $2.1M, -33% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $1.7M; public on 7 Nov 2025
Quarter ended 31 Mar 2026: $1.1M; public on 7 May 2026
Quarter ended 30 Jun 2026: $513K; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $912K, -47% on a year earlier; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 88; public on 14 Feb 2022
31 Mar 2022 report: 94; public on 16 May 2022
30 Jun 2022 report: 87; public on 15 Aug 2022
30 Sep 2022 report: 80; public on 14 Nov 2022
31 Dec 2022 report: 87; public on 14 Feb 2023
31 Mar 2023 report: 79; public on 15 May 2023
30 Jun 2023 report: 72; public on 14 Aug 2023
30 Sep 2023 report: 64; public on 14 Nov 2023
31 Dec 2023 report: 75; public on 14 Feb 2024
31 Mar 2024 report: 76; public on 15 May 2024
30 Jun 2024 report: 71; public on 14 Aug 2024
30 Sep 2024 report: 78; public on 14 Nov 2024
31 Dec 2024 report: 76; public on 14 Feb 2025
31 Mar 2025 report: 85; public on 15 May 2025
30 Jun 2025 report: 81; public on 14 Aug 2025
30 Sep 2025 report: 96; public on 14 Nov 2025
31 Dec 2025 report: 101; public on 17 Feb 2026
31 Mar 2026 report: 102; public on 15 May 2026
30 Jun 2026 report: 98; public on 14 Aug 2026
30 Sep 2026 report: 103; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $9.1M (28 May 2025), higher than 100% of its own history.
  • Insider net buying (open market): Insiders bought a net $0 in the last 12 months (the 12 months before: -$9.8M).
  • Revenue per quarter: Revenue $25.3M in the latest quarter, -19% on a year earlier.
  • Capital spending per quarter: Capital spending $912K in the latest quarter, -47% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 69 insider trades

No trades in the last 90 days; the latest was filed 28 May 2025. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
28 May 2025Aron R. English and 4 others10% ownerSell1,386,060$6.58$9.1MForm 4
16 May 202522NW Fund GP, LLC and 4 others10% ownerSell12,334$7.00$86KForm 4
12 May 202522NW Fund GP, LLC and 4 others10% ownerSell51,496$7.03$362KForm 4
7 May 202522NW GP, Inc. and 4 others10% ownerSell41,091$7.05$290KForm 4
8 Jan 2025Paul JosephsChief Executive OfficerBuy17,000$5.74$98KForm 4
7 Oct 2024Legion Partners Asset Management, LLC and 6 othersDirector, 10% ownerBuy1,463,414$4.10$6.0MForm 4
7 Oct 2024Wynnefield Capital, Inc. Profit Sharing Plan and 7 others10% ownerBuy292,683$4.10$1.2MForm 4
18 Jan 2023Wynnefield Capital Management LLC and 7 others10% ownerBuy627,746$7.97$5.0MForm 4

103 institutions reported shares at the end of Q3 2026, 67% of the shares outstanding; 14 opened a position, 11 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Wynnefield Capital Inc4.9M12.8%$32.0M+165K+3.5%
Legion Partners Asset Management, LLC4.5M11.8%$29.5M+20K+0.4%
325 Capital LLC2.9M7.64%$19.1MNo change
Greenhaven Road Investment Management, L.P.2.9M7.57%$18.9M-322K-10%
BlackRock, Inc.2.0M5.32%$13.3M+5,082+0.3%
Vanguard Capital Management LLC1.3M3.40%$8.5MNo change
Geode Capital Management, LLC849K2.24%$5.6M-6,876-0.8%
Morgan Stanley738K1.95%$4.9M-32K-4.1%
State Street Corp638K1.68%$4.2M-30K-4.5%
Quinn Opportunity Partners LLC539K1.42%$3.5M+86K+19%

In 12 months: 2 director or officer changes, 2 major agreements. Results releases and routine reports are left out.

FiledWhat happenedSource
29 Sep 2026Signed a major agreement8-K
28 Sep 2026Signed a major agreement8-K
5 Jun 2026Director or officer changeSame filing: shareholder vote results8-K
16 Jan 2026Director or officer change8-K
26 Sep 2025Director or officer change8-K
18 Aug 2025Changed its auditor8-K
18 Jul 2025Director or officer change8-K
16 Apr 2025Director or officer change8-K

18 open postings; careers site tracked since 21 Nov 2026. Most in Manufacturing & production 22%, Test, quality & reliability 22%, Program & project management 11%, Supply chain & procurement 11%.

PostedJobLocation
20 Nov 2026Filling Technician - Weekend ShiftChaska, MN, US
19 Nov 2026Manufacturing Engineering Technician - 2nd ShiftManufacturing & productionChaska, MN, US
18 Nov 2026Buyer/PlannerSupply chain & procurementChaska, MN, US
17 Nov 2026Senior Sterility Assurance EngineerChaska, MN, US
16 Nov 2026Fermentation Manufacturing Technician - Weekend PM ShiftManufacturing & productionChaska, MN, US
16 Nov 2026Senior Facility EngineerFacilities & constructionChaska, MN, US
10 Nov 2026Manufacturing ManagerManufacturing & productionChaska, MN, US
5 Nov 2026Manufacturing Inspector - 2nd ShiftManufacturing & productionChaska, MN, US
Timeline

Timeline

Changes and notable records, by the date each became public

  1. 5 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 5 Jun 2026Filings record

    Director or officer change

  3. 16 Jan 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 16 Jan 2026Filings record

    Director or officer change

  5. 26 Sep 2025Filings record

    Director or officer change

  6. 18 Aug 2025Filings record

    Changed its auditor

  7. 18 Jul 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  8. 18 Jul 2025Filings record

    Director or officer change

  9. 16 Apr 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 16 Apr 2025Filings record

    Director or officer change

  11. 9 Jan 2025Insiders record

    Josephs Paul (Chief Executive Officer) bought 17,000 shares of LFCR ($97,580) (dated 8 Jan 2025)

  12. 10 Oct 2024Filings record

    Registered new securities for sale (S-1)

  13. 8 Oct 2024Insiders record

    Legion Partners Asset Management, LLC (director) and 6 other(s) bought 1,463,414 shares of LFCR ($6.0M) (dated 7 Oct 2024)

  14. 8 Oct 2024Insiders record

    Wynnefield Capital, Inc. Profit Sharing Plan (ten percent owner) and 7 other(s) bought 292,683 shares of LFCR ($1.2M) (dated 7 Oct 2024)

  15. 25 Sep 2024Short interest and volume change

    had 2.8M shares sold short in the 13 Sep 2024 report, 1.4× the same report last year.

    Same report last year: 2.0M; its normal report is 1.9M.

    See the evidence
    This period
    2.8M (the 13 Sep 2024 report)
    Normal report (median of 24 earlier)
    1.9M
    Typical spread (median absolute deviation)
    178K
    How far from its usual level
    +3.7
    Same report last year
    2.0M
    History used
    668 days
    2023-09-15: 2.0M2023-09-29: 1.8M2023-10-13: 1.9M2023-10-31: 1.8M2023-11-15: 1.9M2023-11-30: 1.6M2023-12-15: 1.7M2023-12-29: 1.5M2024-01-12: 1.7M2024-01-31: 1.6M2024-02-15: 1.7M2024-02-29: 1.7M2024-03-15: 1.8M2024-03-28: 1.8M2024-04-15: 1.9M2024-04-30: 2.0M2024-05-15: 2.1M2024-05-31: 2.1M2024-06-14: 2.2M2024-06-28: 2.2M2024-07-15: 2.8M2024-07-31: 2.8M2024-08-15: 2.8M2024-08-30: 2.9M2024-09-13: 2.8M
    the 13 Sep 2024 report24 earlier reportsnormal: 1.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 23 Sep 2024Filings record

    Director or officer change

  17. 12 Sep 2024Short interest and volume change

    had 2.9M shares sold short in the 30 Aug 2024 report, 1.6× the same report last year.

    Same report last year: 1.8M; its normal report is 1.8M.

    See the evidence
    This period
    2.9M (the 30 Aug 2024 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    159K
    How far from its usual level
    +4.4
    Same report last year
    1.8M
    History used
    654 days
    2023-08-31: 1.8M2023-09-15: 2.0M2023-09-29: 1.8M2023-10-13: 1.9M2023-10-31: 1.8M2023-11-15: 1.9M2023-11-30: 1.6M2023-12-15: 1.7M2023-12-29: 1.5M2024-01-12: 1.7M2024-01-31: 1.6M2024-02-15: 1.7M2024-02-29: 1.7M2024-03-15: 1.8M2024-03-28: 1.8M2024-04-15: 1.9M2024-04-30: 2.0M2024-05-15: 2.1M2024-05-31: 2.1M2024-06-14: 2.2M2024-06-28: 2.2M2024-07-15: 2.8M2024-07-31: 2.8M2024-08-15: 2.8M2024-08-30: 2.9M
    the 30 Aug 2024 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 29 Aug 2024Filings record

    Director or officer change

  19. 27 Aug 2024Short interest and volume change

    had 2.8M shares sold short in the 15 Aug 2024 report, 1.7× the same report last year.

    Same report last year: 1.7M; its normal report is 1.8M.

    See the evidence
    This period
    2.8M (the 15 Aug 2024 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    122K
    How far from its usual level
    +5.6
    Same report last year
    1.7M
    History used
    639 days
    2023-08-15: 1.7M2023-08-31: 1.8M2023-09-15: 2.0M2023-09-29: 1.8M2023-10-13: 1.9M2023-10-31: 1.8M2023-11-15: 1.9M2023-11-30: 1.6M2023-12-15: 1.7M2023-12-29: 1.5M2024-01-12: 1.7M2024-01-31: 1.6M2024-02-15: 1.7M2024-02-29: 1.7M2024-03-15: 1.8M2024-03-28: 1.8M2024-04-15: 1.9M2024-04-30: 2.0M2024-05-15: 2.1M2024-05-31: 2.1M2024-06-14: 2.2M2024-06-28: 2.2M2024-07-15: 2.8M2024-07-31: 2.8M2024-08-15: 2.8M
    the 15 Aug 2024 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 21 Aug 2024Filings record

    Director or officer change

  21. 12 Aug 2024Filings record

    Report will be filed late

  22. 10 Aug 2024Short interest and volume change

    had 2.8M shares sold short in the 31 Jul 2024 report, 1.7× the same report last year.

    Same report last year: 1.7M; its normal report is 1.8M.

    See the evidence
    This period
    2.8M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    114K
    How far from its usual level
    +5.7
    Same report last year
    1.7M
    History used
    624 days
    2023-07-31: 1.7M2023-08-15: 1.7M2023-08-31: 1.8M2023-09-15: 2.0M2023-09-29: 1.8M2023-10-13: 1.9M2023-10-31: 1.8M2023-11-15: 1.9M2023-11-30: 1.6M2023-12-15: 1.7M2023-12-29: 1.5M2024-01-12: 1.7M2024-01-31: 1.6M2024-02-15: 1.7M2024-02-29: 1.7M2024-03-15: 1.8M2024-03-28: 1.8M2024-04-15: 1.9M2024-04-30: 2.0M2024-05-15: 2.1M2024-05-31: 2.1M2024-06-14: 2.2M2024-06-28: 2.2M2024-07-15: 2.8M2024-07-31: 2.8M
    the 31 Jul 2024 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 25 Jul 2024Short interest and volume change

    had 2.8M shares sold short in the 15 Jul 2024 report, 1.7× the same report last year.

    Same report last year: 1.7M; its normal report is 1.8M.

    See the evidence
    This period
    2.8M (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    114K
    How far from its usual level
    +5.7
    Same report last year
    1.7M
    History used
    608 days
    2023-07-14: 1.7M2023-07-31: 1.7M2023-08-15: 1.7M2023-08-31: 1.8M2023-09-15: 2.0M2023-09-29: 1.8M2023-10-13: 1.9M2023-10-31: 1.8M2023-11-15: 1.9M2023-11-30: 1.6M2023-12-15: 1.7M2023-12-29: 1.5M2024-01-12: 1.7M2024-01-31: 1.6M2024-02-15: 1.7M2024-02-29: 1.7M2024-03-15: 1.8M2024-03-28: 1.8M2024-04-15: 1.9M2024-04-30: 2.0M2024-05-15: 2.1M2024-05-31: 2.1M2024-06-14: 2.2M2024-06-28: 2.2M2024-07-15: 2.8M
    the 15 Jul 2024 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 24 Jul 2024Filings record

    Director or officer change

  25. 12 Jul 2024Filings record

    Restructuring costs announced

  26. 1 Jul 2024Filings record

    Director or officer change

  27. 7 Jun 2024Filings record

    Delisting notice or listing transfer

  28. 22 May 2024Filings record

    Director or officer change

  29. 14 May 2024Filings record

    Delisting notice or listing transfer

  30. 7 May 2024Filings record

    Director or officer change

  31. 30 Apr 2024Filings record

    Changed its auditor

  32. 19 Apr 2024Filings record

    Delisting notice or listing transfer

  33. 8 Apr 2024Filings record

    Report will be filed late

  34. 26 Mar 2024Filings record

    Changed its auditor

  35. 20 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 20 Mar 2024Filings record

    Director or officer change

  37. 16 Feb 2024Filings record

    Delisting notice or listing transfer

  38. 12 Jan 2024Filings record

    Delisting notice or listing transfer

  39. 10 Jan 2024Filings record

    Report will be filed late

  40. 31 Oct 2023Filings record

    Earlier financial statements can no longer be relied on

Showing the newest 40 of 144 entries; narrow the window or the kind of data to see older ones.

Not listed: 144 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001005286
Ticker
LFCR
Domain
lifecore.com
Hq location
MN|CHASKA|55318 (1 unverified)
Name
Camden Fruit Corp, Curation Foods, Inc, Greenline Logistics, Inc, LANDEC CORP \CA\ and 3 more
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)207 records6 Jan 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1186 data points31 May 2009 to 28 Oct 2026
  • SEC Form 4 insider transactions69 records, 240 data points3 Feb 2016 to 28 May 2025
  • FINRA short interest (twice monthly)288 data points15 Nov 2022 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2016 data points15 Nov 2022 to 20 Nov 2026